Plain-English translation of NCT05934474 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers believe that inflammation in the body may play a role in serious mental health conditions like bipolar disorder and schizophrenia. This study is collecting blood samples from people with these diagnoses to look for common inflammatory markers—molecules in the blood that could help doctors better understand and eventually diagnose these conditions. By studying these samples alongside detailed information about your symptoms, the research team hopes to find patterns that could improve how these illnesses are diagnosed and treated in the future.
Right now, doctors diagnose serious mental health conditions mainly by talking with patients about their symptoms, but there are no blood tests to confirm these diagnoses. This study aims to find biological markers in the blood that are common across several psychiatric conditions, which could eventually lead to better, faster diagnoses and more personalized treatment plans.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have one or more appointments at Nantes University Hospital where a nurse will take a small blood sample from your arm. You will also complete some questionnaires and assessment forms about your current symptoms using standardized rating scales. The whole process is straightforward and takes a few hours total. Your blood sample will be stored and studied to look for inflammation-related markers that researchers can analyze alongside your symptom information.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France